Ascendis Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.About ASND
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs.
ASND Key Statistics
Stock Snapshot
Ascendis Pharma(ASND) stock is priced at $206.99, giving the company a market capitalization of 12.48B. It carries a P/E multiple of -48.13.
On 2025-11-17, Ascendis Pharma(ASND) shares started trading at $206.96, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 638.33K.
Over the past 52 weeks, Ascendis Pharma(ASND) stock has traded between a high of $219.30 and a low of $118.03.
Over the past 52 weeks, Ascendis Pharma(ASND) stock has traded between a high of $219.30 and a low of $118.03.
ASND News
Ascendis Pharma reported third-quarter 2025 results showing revenue of €213.63 million and a net loss of €60.99 million, with improved financial performance, gl...
Ascendis Pharma (NasdaqGS:ASND) has caught the attention of investors, with shares fluctuating over the past month. The company’s stock performance reflects shi...
Analyst Yun Zhong from Wedbush maintained a Buy rating on Ascendis Pharma and increased the price target to $220.00 from $212.00. Meet Your ETF AI Analyst Disco...
Analyst ratings
100%
of 15 ratingsMore ASND News
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...
Reports Q3 revenue EUR 213.63M vs. EUR 57.83M last year. “With our achievements in the third quarter and year to date, Ascendis is making great progress toward...